Glatt combines its leading position in pharmaceutical solid
dosage form processing and equipment with a focused approach on
providing innovative and high-quality pharmaceutical contract
development and manufacturing services.
Glatt Pharmaceutical Services is the business
unit of the Glatt Group focused on the development and manufacture
of solid dosage forms. Our particular expertise is in the field of
multi-particulate dosage forms, with over 40 years of know-how and
development experience. This information enables our partners to
market excellent, innovative and convenient drug products applying
our technological, formulation and process expertise.
Glatt has development and manufacturing
capabilities in Germany and the US. Both sites are FDA approved,
while the German site holds an additional EU approval.